Timing and microbiological profile influence long-term outcomes after debridement, antibiotics, and implant retention (DAIR) in acute hip periprosthetic joint infection - Summary - MDSpire

Timing and microbiological profile influence long-term outcomes after debridement, antibiotics, and implant retention (DAIR) in acute hip periprosthetic joint infection

  • By

  • Ernesto Muñoz-Mahamud

  • Juan Carlos Perdomo-Lizarraga

  • Andrés Combalia

  • Alfonso Alías

  • Adrià Serra

  • Jenaro Ángel Fernández-Valencia

  • Miguel Ángel Verdejo

  • Álex Soriano

  • June 23, 2026

  • 0 min

Share

Objective:

To evaluate treatment failure-free survival at five years and identify clinical, microbiological, and procedural predictors of treatment failure in patients with acute hip PJI managed with DAIR.

Approach:
  • Outcome Assessment: Defined treatment failure as revision surgery, additional debridement, long-term suppressive antibiotic therapy, or PJI-related mortality.
Key Findings:
  • Mean follow-up was 7.1 years (SD 4.4), with a range of 0–20.3 years.
  • 76.5% of patients developed infection following primary arthroplasty.
  • The interval between diagnosis and DAIR varied, reflecting real-world clinical practice.
Interpretation:

The study provides insights into long-term outcomes and factors influencing treatment failure in acute hip PJI managed with DAIR.

Limitations:
  • Retrospective design may introduce bias.
  • Inclusion of both primary and aseptic revision arthroplasty may affect outcome generalizability.
  • Variability in timing of DAIR procedures not standardized.
Conclusion:

Further data on mid- to long-term outcomes of DAIR for acute hip PJI is warranted to enhance understanding of treatment efficacy.

Original Source(s)

Related Content